GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Distribution » Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) » Definitions » Median PS Value

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Median PS Value : ¥0.00 (As of May. 20, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Sichuan Goldstone Asia Pharmaceutical Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Sichuan Goldstone Asia Pharmaceutical's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.807. Sichuan Goldstone Asia Pharmaceutical's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is ¥0.00.

As of today (2024-05-20), Sichuan Goldstone Asia Pharmaceutical's share price is ¥9.05. Sichuan Goldstone Asia Pharmaceutical's Median PS Value is ¥0.00. Therefore, Sichuan Goldstone Asia Pharmaceutical's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Sichuan Goldstone Asia Pharmaceutical's Median PS Value or its related term are showing as below:

SZSE:300434's Price-to-Median-PS-Value is not ranked *
in the Industrial Distribution industry.
Industry Median: 1.04
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Sichuan Goldstone Asia Pharmaceutical Median PS Value Historical Data

The historical data trend for Sichuan Goldstone Asia Pharmaceutical's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Goldstone Asia Pharmaceutical Median PS Value Chart

Sichuan Goldstone Asia Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sichuan Goldstone Asia Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sichuan Goldstone Asia Pharmaceutical's Median PS Value

For the Industrial Distribution subindustry, Sichuan Goldstone Asia Pharmaceutical's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sichuan Goldstone Asia Pharmaceutical's Price-to-Median-PS-Value Distribution in the Industrial Distribution Industry

For the Industrial Distribution industry and Industrials sector, Sichuan Goldstone Asia Pharmaceutical's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Sichuan Goldstone Asia Pharmaceutical's Price-to-Median-PS-Value falls into.



Sichuan Goldstone Asia Pharmaceutical Median PS Value Calculation

Sichuan Goldstone Asia Pharmaceutical's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=2.807*0
=0.00

10-Year Median PS Ratio is 0.
Sichuan Goldstone Asia Pharmaceutical's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.807.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sichuan Goldstone Asia Pharmaceutical  (SZSE:300434) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Sichuan Goldstone Asia Pharmaceutical's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=9.05/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sichuan Goldstone Asia Pharmaceutical Median PS Value Related Terms

Thank you for viewing the detailed overview of Sichuan Goldstone Asia Pharmaceutical's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Business Description

Traded in Other Exchanges
N/A
Address
8 Jiayuan Road, 8th Floor, District A1, Dadi Xinguanghua Plaza, Chengdu, CHN, 610072
Sichuan Goldstone Asia Pharmaceutical Inc is engaged in development and application of steel-reinforced plastic composite pipe technology, providing customers with steel-reinforced plastic composite pipes from pipe structure, production process to construction technology. The company is also engaged in research and development, production and sales of medicines and health products.

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Headlines

No Headlines